Brazil and Paraguay signed an agreement to enhance health surveillance standards in Latin America, focusing on combating irregular, counterfeit, and illegitimate medicines. Involves ANVISA and DINAVISA, aiming for agile and coordinated regulatory responses through shared intelligence and methodologies. Goals include stronger regulation, patient safety, market integrity, harmonization of best practices, and creating a technical barrier against illegal trade. Serves as basis for future technical negotiations and joint actions.

Select Mandate HA
Select Mandate Function